"The fundamental elements of generative AI are showing a lot of promise in streamlining the pillars of autonomous navigation ...

History may soon repeat itself with a novel new platform: networks of AI agents carrying out instructions from prompts and sharing them with other AI agents, which could spread the instructions ...

Discover the world of Recursive Self-Improvement (RSI) in AI. From I.J. Good's intelligence explosion to modern self-healing code and clinical applications, explore who is developing it, how it works, ...

NASA’s Perseverance rover has just made history by driving across Mars using routes planned by artificial intelligence instead of human operators. A vision-capable AI analyzed the same images and ...

This week, researchers identified the role of the brain's protein clean-up system in dementia. Fecal transplants show promising benefits in treating multiple cancer types. And biologists found that ...

This week’s largest fundraising recipient was frontier AI lab Recursive Intelligence, and agentic AI, AI-compute, and AI-native startups filled up much of the rest of the Top 10 list.

Computer Science majors Owen McGann ’26 and Yousef Sengal ’27 spent last summer conducting research on Human-Robot ...

Artificial intelligence is moving beyond standalone large language model wrappers toward collections of specialized AI agents that reason, act, ...

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...